Guided Therapeutics (GTHP) Prepaid Assets (2010 - 2025)
Guided Therapeutics (GTHP) reported Prepaid Assets of $90000.0 for Q4 2025, down 47.98% on a YoY basis from $173000.0 in Q4 2024, and down 26.83% sequentially from $123000.0 in Q3 2025.
Guided Therapeutics (GTHP) Prepaid Assets (2010 - 2025) Analysis & Trends
Guided Therapeutics (GTHP) has 16 years of Prepaid Assets data on file, last reported at $90000.0 in Q4 2025.
- For the quarter ending Q4 2025, Prepaid Assets fell 47.98% year-over-year to $90000.0; the trailing twelve-month figure through Dec 2025 stood at $90000.0 (down 47.98% YoY), and the FY2025 full-year result was $90000.0, down 47.98% from the prior year.
- Prepaid Assets slipped to $90000.0 in Q4 2025, from $123000.0 in the prior quarter.
- In the past five years, Prepaid Assets ranged from a high of $453000.0 in Q1 2022 to a low of $23000.0 in Q2 2025.
- A 5-year average of $149200.0 and a median of $130000.0 in 2022 frame the typical range for Prepaid Assets.
- Across the five-year window, Prepaid Assets soared 1061.54% in 2022 and plunged 79.46% in 2025, its largest moves.
- Tracing GTHP's Prepaid Assets over 5 years: stood at $377000.0 in 2021, then tumbled by 63.66% to $137000.0 in 2022, then increased by 18.98% to $163000.0 in 2023, then advanced by 6.13% to $173000.0 in 2024, then slumped by 47.98% to $90000.0 in 2025.
- Business Quant data shows GTHP's Prepaid Assets at $90000.0 in Q4 2025, $123000.0 in Q3 2025, and $23000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | Guided Therapeutics | 21.96 Mn | 21.89 Mn | 458,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 90,000.00 |
| Sep 30, 2025 | 123,000.00 |
| Jun 30, 2025 | 23,000.00 |
| Mar 31, 2025 | 61,000.00 |
| Dec 31, 2024 | 173,000.00 |
| Sep 30, 2024 | 211,000.00 |
| Jun 30, 2024 | 112,000.00 |
| Mar 31, 2024 | 156,000.00 |
| Dec 31, 2023 | 163,000.00 |
| Sep 30, 2023 | 192,000.00 |
| Jun 30, 2023 | 91,000.00 |
| Mar 31, 2023 | 121,000.00 |
| Dec 31, 2022 | 137,000.00 |
| Sep 30, 2022 | 169,000.00 |
| Jun 30, 2022 | 59,000.00 |
| Mar 31, 2022 | 453,000.00 |
| Dec 31, 2021 | 377,000.00 |
| Sep 30, 2021 | 173,000.00 |
| Jun 30, 2021 | 61,000.00 |
| Mar 31, 2021 | 39,000.00 |